{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,1,21]],"date-time":"2026-01-21T20:09:17Z","timestamp":1769026157536,"version":"3.49.0"},"reference-count":38,"publisher":"Elsevier BV","issue":"1-3","license":[{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2013,12,1]],"date-time":"2013-12-01T00:00:00Z","timestamp":1385856000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"}],"funder":[{"DOI":"10.13039\/501100004085","name":"Ministry of Education, Science and Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100004085","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002994","name":"Ministry of Knowledge Economy","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100002994","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003704","name":"Korea Research Institute of Chemical Technology","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100003704","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["European Journal of Pharmacology"],"published-print":{"date-parts":[[2013,12]]},"DOI":"10.1016\/j.ejphar.2013.09.052","type":"journal-article","created":{"date-parts":[[2013,10,14]],"date-time":"2013-10-14T12:01:20Z","timestamp":1381752080000},"page":"70-79","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":13,"title":["Anti-diabetic and anti-inflammatory effect of a novel selective 11\u03b2-HSD1 inhibitor in the diet-induced obese mice"],"prefix":"10.1016","volume":"721","author":[{"given":"Sung Bum","family":"Park","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Won Hoon","family":"Jung","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nam Sook","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ji Seon","family":"Park","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Gyu Hwan","family":"Bae","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hee Youn","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Sang Dal","family":"Rhee","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Seung Kyu","family":"Kang","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jin Hee","family":"Ahn","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Hye Gwang","family":"Jeong","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Ki Young","family":"Kim","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"key":"10.1016\/j.ejphar.2013.09.052_bib1","doi-asserted-by":"crossref","first-page":"1826","DOI":"10.1038\/sj.ijo.0803677","article-title":"Type 2 diabetes and metabolic syndrome are associated with increased expression of 11beta-hydroxysteroid dehydrogenase 1 in obese subjects","volume":"31","author":"Alberti","year":"2007","journal-title":"Int. J. Obes. (Lond)"},{"key":"10.1016\/j.ejphar.2013.09.052_bib2","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1007\/s00125-002-0959-6","article-title":"Selective inhibition of 11beta-hydroxysteroid dehydrogenase type 1 decreases blood glucose concentrations in hyperglycaemic mice","volume":"45","author":"Alberts","year":"2002","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2013.09.052_bib3","doi-asserted-by":"crossref","first-page":"2277","DOI":"10.2337\/diabetes.54.8.2277","article-title":"Reduction of macrophage infiltration and chemoattractant gene expression changes in white adipose tissue of morbidly obese subjects after surgery-induced weight loss","volume":"54","author":"Cancello","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2013.09.052_bib4","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1016\/j.ab.2009.04.038","article-title":"Cell-based assay for screening 11beta hydroxysteroid dehydrogenase 1 inhibitors","volume":"392","author":"Cho","year":"2009","journal-title":"Anal. Biochem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib5","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1096\/fasebj.13.2.305","article-title":"A role for preadipocytes as macrophage-like cells","volume":"13","author":"Cousin","year":"1999","journal-title":"Faseb. J."},{"key":"10.1016\/j.ejphar.2013.09.052_bib6","doi-asserted-by":"crossref","first-page":"309","DOI":"10.1677\/JOE-08-0568","article-title":"Bone loss in inflammatory disorders","volume":"201","author":"Hardy","year":"2009","journal-title":"J. Endocrinol."},{"key":"10.1016\/j.ejphar.2013.09.052_bib7","doi-asserted-by":"crossref","first-page":"653","DOI":"10.1016\/j.physbeh.2004.09.016","article-title":"The new concept of adipose tissue function","volume":"83","author":"Hauner","year":"2000","journal-title":"Physiol. Behav."},{"key":"10.1016\/j.ejphar.2013.09.052_bib8","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1055\/s-2004-814570","article-title":"Hypothalamic regulation of adiposity: the role of 11beta-hydroxysteroid dehydrogenase type 1","volume":"36","author":"Hochberg","year":"2004","journal-title":"Horm. Metab. Res."},{"key":"10.1016\/j.ejphar.2013.09.052_bib9","doi-asserted-by":"crossref","first-page":"860","DOI":"10.1038\/nature05485","article-title":"Inflammation and metabolic disorders","volume":"444","author":"Hotamisligil","year":"2006","journal-title":"Nature"},{"issue":"5","key":"10.1016\/j.ejphar.2013.09.052_bib10","doi-asserted-by":"crossref","first-page":"E930","DOI":"10.1152\/ajpendo.00320.2009","article-title":"Glucocorticoid reamplification within cells intensifies NF-kappaB and MAPK signaling and reinforces inflammation in activated preadipocytes","volume":"298","author":"Ishii-Yonemoto","year":"2010","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2013.09.052_bib11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1002\/j.1550-8528.1996.tb00525.x","article-title":"Abnormal regulation of hepatic glucocorticoid receptor mRNA and receptor protein distribution in the obese Zucker rat","volume":"4","author":"Jenson","year":"1996","journal-title":"Obesity Res."},{"key":"10.1016\/j.ejphar.2013.09.052_bib12","doi-asserted-by":"crossref","first-page":"3953","DOI":"10.1021\/jm800310g","article-title":"Discovery of novel, potent benzamide inhibitors of 11betahydroxysteroid dehydrogenase type 1 (11beta-HSD1) exhibiting oral activity in an enzyme inhibition ex vivo model","volume":"51","author":"Julian","year":"2008","journal-title":"J. Med. Chem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib13","doi-asserted-by":"crossref","first-page":"293","DOI":"10.1016\/S0022-2275(20)38388-7","article-title":"Scanning electron microscopy of very small fat cells and mature fat cells in human obesity","volume":"30","author":"Julien","year":"1989","journal-title":"J. Lipid Res."},{"key":"10.1016\/j.ejphar.2013.09.052_bib14","doi-asserted-by":"crossref","first-page":"14924","DOI":"10.1073\/pnas.94.26.14924","article-title":"11beta-hydroxysteroid dehydrogenase type 1 knockout mice show attenuated glucocorticoid-inducible responses and resist hyperglycemia on obesity or stress","volume":"94","author":"Kotelevtsev","year":"1997","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.ejphar.2013.09.052_bib15","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/j.bmcl.2010.10.123","article-title":"Synthesis and 11\u03b2 hydroxysteroid dehydrogenase 1 inhibition of thiazolidine derivatives with an adamantyl group","volume":"21","author":"Kwon","year":"2011","journal-title":"Bioorg. Med. Chem. Lett."},{"key":"10.1016\/j.ejphar.2013.09.052_bib16","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2337\/diabetes.54.1.32","article-title":"Increased glucocorticoid receptor and 11\u03b2-hydroxysteroid dehydrogenase type 1 expression in hepatocytes may contribute to the phenotype of type 2 diabetes in db\/db mice","volume":"54","author":"Liu","year":"2005","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2013.09.052_bib17","doi-asserted-by":"crossref","first-page":"343","DOI":"10.1152\/physiolgenomics.00067.2007","article-title":"Suppression of 11beta-hydroxysteroid dehydrogenase type 1 with RNA interference substantially attenuates 3T3-L1 adipogenesis","volume":"32","author":"Liu","year":"2008","journal-title":"Physiol. Genomics"},{"key":"10.1016\/j.ejphar.2013.09.052_bib18","doi-asserted-by":"crossref","first-page":"2166","DOI":"10.1126\/science.1066285","article-title":"A transgenic model of visceral obesity and the metabolic syndrome","volume":"294","author":"Masuzaki","year":"2001","journal-title":"Science"},{"key":"10.1016\/j.ejphar.2013.09.052_bib19","doi-asserted-by":"crossref","first-page":"1707","DOI":"10.1007\/s00125-007-0708-y","article-title":"Enhanced proportion of small adipose cells in insulin-resistant vs. insulin-sensitive obese individuals implicates impaired adipogenesis","volume":"50","author":"McLaughlin","year":"2007","journal-title":"Diabetologia"},{"key":"10.1016\/j.ejphar.2013.09.052_bib20","doi-asserted-by":"crossref","first-page":"41293","DOI":"10.1074\/jbc.M103676200","article-title":"Improved lipid and lipoprotein profile, hepatic insulin sensitivity, and glucose tolerance in 11beta-hydroxysteroid dehydrogenase type 1 null mice","volume":"276","author":"Morton","year":"2001","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib21","doi-asserted-by":"crossref","first-page":"931","DOI":"10.2337\/diabetes.53.4.931","article-title":"Novel adipose tissue-mediated resistance to diet-induced visceral obesity in 11 beta-hydroxysteroid dehydrogenase type 1-deficient mice","volume":"53","author":"Morton","year":"2004","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2013.09.052_bib22","doi-asserted-by":"crossref","first-page":"E1517","DOI":"10.1152\/ajpendo.00522.2007","article-title":"Carbenoxolone treatment attenuates symptoms of metabolic syndrome and atherogenesis in obese, hyperlipidemic mice","volume":"293","author":"Nuotio-Antar","year":"2007","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2013.09.052_bib24","doi-asserted-by":"crossref","first-page":"1028","DOI":"10.1016\/j.bcp.2011.01.020","article-title":"Anti-diabetic and anti-adipogenic effects of a novel selective 11beta-hydroxysteroid dehydrogenase type 1 inhibitor, 2-(3-benzoyl)-4-hydroxy-1,1-dioxo-2h-1,2-benzothiazine-2-yl-1-phenylethanone (kr-66344)","volume":"81","author":"Park","year":"2011","journal-title":"Biochem. Pharmacol."},{"key":"10.1016\/j.ejphar.2013.09.052_bib25","doi-asserted-by":"crossref","first-page":"7088","DOI":"10.1073\/pnas.0305524101","article-title":"Metabolic syndrome without obesity: hepatic overexpression of 11beta-hydroxysteroid dehydrogenase type 1 in transgenic mice","volume":"101","author":"Paterson","year":"2004","journal-title":"Proc. Natl. Acad. Sci. USA"},{"issue":"9","key":"10.1016\/j.ejphar.2013.09.052_bib26","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.2337\/db09-1452","article-title":"Beta-cell failure in diet-induced obese mice stratified according to body weight gain: secretory dysfunction and altered islet lipid metabolism without steatosis or reduced beta-cell mass","volume":"59","author":"Peyot","year":"2010","journal-title":"Diabetes"},{"key":"10.1016\/j.ejphar.2013.09.052_bib27","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.1056\/NEJMra050541","article-title":"Antiinflammatory action of glucocorticoids-new mechanisms for old drugs","volume":"353","author":"Rhen","year":"2005","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.ejphar.2013.09.052_bib28","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1038\/nrm2066","article-title":"Adipocyte differentiation from the inside out","volume":"7","author":"Rosen","year":"2006","journal-title":"Nat. Rev. Mol. Cell Biol."},{"key":"10.1016\/j.ejphar.2013.09.052_bib29","doi-asserted-by":"crossref","first-page":"1516","DOI":"10.2337\/dc09-2315","article-title":"The 11-beta-hydroxysteroid dehydrogenase type 1 inhibitor incb13739 improves hyperglycemia in patients with type 2 diabetes inadequately controlled by metformin monotherapy","volume":"33","author":"Rosenstock","year":"2010","journal-title":"Diabetes Care"},{"key":"10.1016\/j.ejphar.2013.09.052_bib30","doi-asserted-by":"crossref","first-page":"6106","DOI":"10.1523\/JNEUROSCI.5332-09.2010","article-title":"Rapid glucocorticoid receptor-mediated inhibition of hypothalamic-pituitary-adrenal ultradian activity in healthy males","volume":"30","author":"Russell","year":"2010","journal-title":"J. Neurosci."},{"key":"10.1016\/j.ejphar.2013.09.052_bib31","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1210\/jc.2002-021127","article-title":"Novel insulin sensitivity index derived from oral glucose tolerance test","volume":"88","author":"Soonthornpun","year":"2003","journal-title":"J. Clin. Endocrinol. Metab."},{"key":"10.1016\/j.ejphar.2013.09.052_bib32","first-page":"3988","article-title":"Accessory factors facilitate the binding of glucocorticoid receptor to the phosphoenolpyruvate carboxykinase gene promoter","volume":"276","author":"Stafford","year":"2001","journal-title":"J. Biolo. Chem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib33","doi-asserted-by":"crossref","first-page":"441","DOI":"10.1515\/BC.2008.049","article-title":"Sub-chronic administration of the 11beta-HSD1 inhibitor, carbenoxolone, improves glucose tolerance and insulin sensitivity in mice with diet-induced obesity","volume":"389","author":"Taylor","year":"2008","journal-title":"Biol. Chem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib34","doi-asserted-by":"crossref","first-page":"31615","DOI":"10.1074\/jbc.273.47.31615","article-title":"Perturbation of fuel homeostasis caused by overexpression of the glucose-6-phosphatase catalytic subunit in liver of normal rats","volume":"273","author":"Trinh","year":"1998","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.ejphar.2013.09.052_bib35","doi-asserted-by":"crossref","first-page":"513","DOI":"10.1042\/bj3620513","article-title":"The glucose-6-phosphatase system","volume":"362","author":"Van, Schaftingen","year":"2002","journal-title":"Biochem. J."},{"key":"10.1016\/j.ejphar.2013.09.052_bib36","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1016\/S1093-3263(02)00164-X","article-title":"Ligandfit: a novel method for the shape-directed rapid docking of ligands to protein active sites","volume":"21","author":"Venkatachalam","year":"2003","journal-title":"J. Mol. Graph Model"},{"key":"10.1016\/j.ejphar.2013.09.052_bib37","doi-asserted-by":"crossref","first-page":"1796","DOI":"10.1172\/JCI200319246","article-title":"Obesity is associated with macrophage accumulation in adipose tissue","volume":"112","author":"Weisberg","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2013.09.052_bib39","doi-asserted-by":"crossref","first-page":"1821","DOI":"10.1172\/JCI200319451","article-title":"Chronic inflammation in fat plays a crucial role in the development of obesity-related insulin resistance","volume":"112","author":"Xu","year":"2003","journal-title":"J. Clin. Invest."},{"key":"10.1016\/j.ejphar.2013.09.052_bib40","doi-asserted-by":"crossref","first-page":"6948","DOI":"10.1021\/bi047599q","article-title":"Crystal structure of murine 11 beta-hydroxysteroid dehydrogenase 1: an important therapeutic target for diabetes","volume":"44","author":"Zhang","year":"2005","journal-title":"Biochemistry"}],"container-title":["European Journal of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007164?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0014299913007164?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,9,15]],"date-time":"2025-09-15T22:19:33Z","timestamp":1757974773000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0014299913007164"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2013,12]]},"references-count":38,"journal-issue":{"issue":"1-3","published-print":{"date-parts":[[2013,12]]}},"alternative-id":["S0014299913007164"],"URL":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.052","relation":{},"ISSN":["0014-2999"],"issn-type":[{"value":"0014-2999","type":"print"}],"subject":[],"published":{"date-parts":[[2013,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Anti-diabetic and anti-inflammatory effect of a novel selective 11\u03b2-HSD1 inhibitor in the diet-induced obese mice","name":"articletitle","label":"Article Title"},{"value":"European Journal of Pharmacology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.ejphar.2013.09.052","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2013 Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}